Leave-nothing-behind in calcified left main disease: expanding the boundaries of contemporary percutaneous coronary intervention
Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
DCB Academy, Milan, Italy
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland
Article file
- Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-coated balloons for coronary artery disease: Third Report of the International DCB Consensus Group. JACC Cardiovasc Interv 2020; 13: 1391-402.
- Fezzi S, Scheller B, Cortese B, et al. Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium. Eur Heart J 2025; 46: 2498-519.
- Iwanczyk S, Lazar FL, Onea HL, et al. Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison. Int J Cardiol 2024; 415: 132436.
- Wanha W, Iwanczyk S, Januszek R, et al. Long-term outcomes following sirolimus-coated balloon or drug-eluting stents for treatment of in-stent restenosis. Circ Cardiovasc Interv 2024; 17: e014064.
- Wanha W, Iwanczyk S, Tajstra M, Cortese B. How to treat coronary in-stent restenosis? Recent advances and their practical implications: state-of-the-art review. Kardiol Pol 2025; 83: 556-69.
- Januszek R, Iwanczyk S, Wojakowski W, et al. Temporal trends in the use of drug-coated balloons in Poland - an analysis based on the national registry. Cardiol J 2026; 33: e00226020.
- Cortese B, Mehilli J, Belmonte M, et al. Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis. Eur Heart J 2026; 47: 2035-43.
- Wanha W, Ullah I, Gurgoglione FL, et al. Comparison of percutaneous intervention with drug coated balloons and drug eluting stents for de novo coronary artery disease: CIRCE, a systematic review and meta-analysis. Am J Cardiol 2026; 271: 98-105.
- Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e18-114.
- Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 2024; 45: 3415-537.
- Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016; 375: 2223-35.
- Holm NR, Makikallio T, Lindsay MM, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 2020; 395: 191-9.
- Wang H, Sun Y, Yi X, Zhang L. Evaluation of the Framingham risk score and pooled cohort risk equation for prediction of cardiovascular risk in low resource areas: Insights from Asian rural population. Int J Cardiol 2018; 265: 237.
- Madhavan MV, Tarigopula M, Mintz GS, et al. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol 2014; 63: 1703-14.
- Guedeney P, Claessen BE, Mehran R, et al. Coronary calcification and long-term outcomes according to drug-eluting stent generation. JACC Cardiovasc Interv 2020; 13: 1417-28.
- Kereiakes DJ, Di Mario C, Riley RF, et al. Intravascular lithotripsy for treatment of calcified coronary lesions: patient-level pooled analysis of the disrupt CAD studies. JACC Cardiovasc Interv 2021; 14: 1337-48.
- Wozniak P, Stepien K, Wanha W, et al. One-year prognosis for patients diagnosed with acute coronary syndrome compared to those with chronic coronary syndrome following complex coronary procedures. J Clin Med 2025; 14: 730.
- Wanha W, Kuzma L, Swieczkowski M, et al. Intravascular imaging-guided percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis. Catheter Cardiovasc Interv 2026; doi:10.1002/ccd.70672.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
